A novel low energy electron microscope for DNA sequencing and surface analysis.

Area of Science:

• Surface Science and Nanotechnology
• Electron Microscopy and Spectroscopy
• Biophysics and Genomics

Background:

• Conventional low-energy electron microscopy (LEEM) faces limitations in resolution and charging effects when imaging insulating specimens.
• Existing techniques struggle to provide high-resolution, label-free imaging of biological macromolecules like DNA.
• Sub-nanometer resolution is crucial for applications such as DNA sequencing, requiring precise identification of individual bases.

Purpose of the Study:

• To introduce and characterize a novel Monochromatic, Aberration-corrected, Dual-beam Low Energy Electron Microscopy (MAD-LEEM) instrument.
• To demonstrate the capability of MAD-LEEM for high-resolution imaging of nanostructures and surfaces.
• To explore the potential of MAD-LEEM for label-free DNA sequencing by achieving base-specific contrast.

Main Methods:

• Integration of a monochromator, mirror aberration corrector, energy filter, and dual flood illumination into a single LEEM instrument.
• Utilizing low electron landing energies (as low as 100 eV) to minimize sample damage and enhance contrast.
• Developing image contrast simulations to correlate experimental measurements with the detectability of individual DNA bases.

Main Results:

• The MAD-LEEM design predicts the elimination of chromatic and spherical aberrations, enabling sub-nanometer spatial resolution.
• Dual beam illumination effectively suppresses charging effects on insulating specimens.
• Experimental results show base-specific contrast using reflected, photo-emitted, and Auger electrons from immobilized oligonucleotides.

Conclusions:

• MAD-LEEM is a powerful new technique for high-resolution imaging of nanostructures and surfaces.
• The instrument's capabilities, including dual beam illumination and aberration correction, overcome limitations of conventional LEEM.
• MAD-LEEM presents a promising avenue for high-speed, label-free DNA sequencing with potential for reduced costs.